Javascript must be enabled to continue!
TO STUDY PROGNOSTIC FACTORS IN PERFORATION PERITONITIS AND EVALUATING THE OUTCOME OF PATIENTS WITH PERFORATION PERITONITIS USING MANNHEIM PERITONITIS INDEX
View through CrossRef
BACKGROUND: Perforation peritonitis constitutes one of the commonest surgical emergency operation encountered
by surgeons all over world as well as in India.There is no single,easily available laboratory test that predicts severity or
prognosis in patients with perforation peritonitis. The aim of this study is to study prognostic factors in perforation
peritonitis and evaluating the outcome of patients with perforation peritonitis using Mannhein Peritonitis Index.
MATERIALS AND METHOD:The study was a prospective analytical study done in the Department of General Surgery,
JNIMS,Imphal from 1st September 2017 to 31st august 2019 comprising of 100 consecutive patients in which diagnosis of
perforation peritonitis were established by operative findings or surgical interventions during management were
included in the study as per the inclusion and exclusion criteria.
RESULTS: Among the various prognostic factors of the scoring system, age >50 years, nature of peritoneal fluid
exudates and presence of organ failure had a significant role in predicting the eventual outcome of the patients.Colonic
origin of sepsis was associated with worse outcome probably due to presence of faecal exudates which is commonly
associated with colonic origin of sepsis. MPI < 21 was associated wih complications in 25% of patients whereas
complications increases as MPI score increases with 34.5% of patients having complication in MPI ranging from 21-29.
CONCLUSION: MPI is disease specific, easy scoring system for predicting outcomes in patients with perforation
peritonitis
Title: TO STUDY PROGNOSTIC FACTORS IN
PERFORATION PERITONITIS AND EVALUATING
THE OUTCOME OF PATIENTS WITH
PERFORATION PERITONITIS USING MANNHEIM
PERITONITIS INDEX
Description:
BACKGROUND: Perforation peritonitis constitutes one of the commonest surgical emergency operation encountered
by surgeons all over world as well as in India.
There is no single,easily available laboratory test that predicts severity or
prognosis in patients with perforation peritonitis.
The aim of this study is to study prognostic factors in perforation
peritonitis and evaluating the outcome of patients with perforation peritonitis using Mannhein Peritonitis Index.
MATERIALS AND METHOD:The study was a prospective analytical study done in the Department of General Surgery,
JNIMS,Imphal from 1st September 2017 to 31st august 2019 comprising of 100 consecutive patients in which diagnosis of
perforation peritonitis were established by operative findings or surgical interventions during management were
included in the study as per the inclusion and exclusion criteria.
RESULTS: Among the various prognostic factors of the scoring system, age >50 years, nature of peritoneal fluid
exudates and presence of organ failure had a significant role in predicting the eventual outcome of the patients.
Colonic
origin of sepsis was associated with worse outcome probably due to presence of faecal exudates which is commonly
associated with colonic origin of sepsis.
MPI < 21 was associated wih complications in 25% of patients whereas
complications increases as MPI score increases with 34.
5% of patients having complication in MPI ranging from 21-29.
CONCLUSION: MPI is disease specific, easy scoring system for predicting outcomes in patients with perforation
peritonitis.
Related Results
MPI score assessment of perforation peritonitis patients
MPI score assessment of perforation peritonitis patients
The most widespread clinical emergency in India is perforation peritonitis. Following improvements in operational procedures, antimicrobial treatments, and care in ICUs, peritoniti...
MO702: Etiology and the Impact of Refractory Peritonitis on Clinical Outcomes of Patients on Peritoneal Dialysis—12 Years’ Single-Center Experience from Turkey
MO702: Etiology and the Impact of Refractory Peritonitis on Clinical Outcomes of Patients on Peritoneal Dialysis—12 Years’ Single-Center Experience from Turkey
Abstract
BACKGROUND AND AIMS
The outcomes of refractory peritonitis in peritoneal dialysis (PD) patients have been reported to b...
Pola Kasus dan Penatalaksanaan Peritonitis Akut di Bangsal Bedah RSUP Dr. M. Djamil Padang
Pola Kasus dan Penatalaksanaan Peritonitis Akut di Bangsal Bedah RSUP Dr. M. Djamil Padang
AbstrakPeritonitis menjadi salah satu penyebab tersering akut abdomen yang merupakan suatu kegawatan abdomen. Peritonitis biasanya disertai dengan bakterisemia atau sepsis yang dap...
EVALUATION OF THE PREDICTIVE ABILITY OF THE MANNHEIM PERITONITIS INDEX (MPI) IN PATIENTS WITH SECONDARY PERITONITIS
EVALUATION OF THE PREDICTIVE ABILITY OF THE MANNHEIM PERITONITIS INDEX (MPI) IN PATIENTS WITH SECONDARY PERITONITIS
Background:Secondary peritonitis is a major cause of morbidity and mortality worldwide, particularly in resource-limited settings. Several prognostic scoring systems ha...
Mannheim Curves in 3-Dimensional Euclidean Space
Mannheim Curves in 3-Dimensional Euclidean Space
In this paper, we consider the Mannheim curve and the slant helix together. We called this curve as a Mannheim slant helix shortly. First we calculate the (first) curvature ????(??...
Validity of Mannheim Peritonitis Index Score in Patients with Secondary Peritonitis
Validity of Mannheim Peritonitis Index Score in Patients with Secondary Peritonitis
Introduction:
Peritonitis accounts for 1% of emergent hospital admissions and overall mortality is 6% to 35% in patients who develop severe sepsis. Many scoring systems...
Gravel Placement Through Perforations and Perforation Cleaning for Gravel Packing
Gravel Placement Through Perforations and Perforation Cleaning for Gravel Packing
Gravel Placement Through Perforations and Perforation Cleaning Perforations and Perforation Cleaning for Gravel Packing
Summary.
...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

